Shares Of Agilon Health Inc (NYSE: AGL) Gain 0.56% In A Month

Agilon Health Inc (NYSE:AGL) has a beta value of 0.53 and has seen 5.01 million shares traded in the last trading session. The company, currently valued at $2.22B, closed the last trade at $5.41 per share which meant it lost -$0.17 on the day or -3.05% during that session. The AGL stock price is -334.01% off its 52-week high price of $23.48 and 18.48% above the 52-week low of $4.41. The 3-month trading volume is 4.70 million shares.

Agilon Health Inc (NYSE:AGL) trade information

Sporting -3.05% in the red in last session, the stock has traded in the green over the last five days, when the AGL stock price touched $5.41 or saw a rise of 5.25%. Year-to-date, Agilon Health Inc shares have moved -56.89%, while the 5-day performance has seen it change 4.24%. Over the past 30 days, the shares of Agilon Health Inc (NYSE:AGL) have changed 0.56%.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free
Sponsored

Agilon Health Inc (AGL) estimates and forecasts

Figures show that Agilon Health Inc shares have outperformed across the wider relevant industry. The company’s shares have lost -56.69% over the past 6 months, with this year growth rate of 30.43%, compared to 12.90% for the industry. Revenue growth from the last financial year stood is estimated to be 43.20%.

13 analysts offering their estimates for the company have set an average revenue estimate of 1.56B for the current quarter. 15 have an estimated revenue figure of 1.55B for the next ending quarter. Year-ago sales stood 1.15B and 1.22B respectively for this quarter and the next, and analysts expect sales will grow by 35.60% for the current quarter and 43.20% for the next.

If we evaluate the company’s growth over the last 5-year and for the next 5-year period, we find that annual earnings growth was 7.65% over the past 5 years.

AGL Dividends

Agilon Health Inc is expected to release its next earnings report in June this year, and investors are excited at the prospect of better dividends despite the company’s debt issue.